BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, van der Poll T. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009;31:280-4. [PMID: 19218854 DOI: 10.1097/SHK.0b013e318186262d] [Cited by in Crossref: 192] [Cited by in F6Publishing: 118] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 van Zoelen MA, Achouiti A, van der Poll T. The role of receptor for advanced glycation endproducts (RAGE) in infection. Crit Care 2011;15:208. [PMID: 21457506 DOI: 10.1186/cc9990] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
2 Zhu S, Li W, Ward MF, Sama AE, Wang H. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 2010;9:60-72. [PMID: 19906009 DOI: 10.2174/187152810791292872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
3 Li LC, Gao J, Li J. Emerging role of HMGB1 in fibrotic diseases. J Cell Mol Med 2014;18:2331-9. [PMID: 25284457 DOI: 10.1111/jcmm.12419] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
4 Weber DJ, Gracon AS, Ripsch MS, Fisher AJ, Cheon BM, Pandya PH, Vittal R, Capitano ML, Kim Y, Allette YM. The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation. Sci Transl Med. 2014;6:252ra124. [PMID: 25186179 DOI: 10.1126/scitranslmed.3009443] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
5 Clark IA, Vissel B. Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease. Br J Pharmacol 2015;172:3714-27. [PMID: 25939581 DOI: 10.1111/bph.13181] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
6 Saenz R, Messmer B, Futalan D, Tor Y, Larsson M, Daniels G, Esener S, Messmer D. Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization. Mol Immunol 2014;57:191-9. [PMID: 24172222 DOI: 10.1016/j.molimm.2013.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kataoka H, Saeki A, Hasebe A, Shibata KI, Into T. Naringenin suppresses Toll-like receptor 2-mediated inflammatory responses through inhibition of receptor clustering on lipid rafts. Food Sci Nutr 2021;9:963-72. [PMID: 33598179 DOI: 10.1002/fsn3.2063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Xu G, Wang J, Gao GF, Liu CH. Insights into battles between Mycobacterium tuberculosis and macrophages. Protein Cell 2014;5:728-36. [PMID: 24938416 DOI: 10.1007/s13238-014-0077-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
9 Romero R, Chaiworapongsa T, Savasan ZA, Hussein Y, Dong Z, Kusanovic JP, Kim CJ, Hassan SS. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med 2012;25:558-67. [PMID: 22578261 DOI: 10.3109/14767058.2011.599083] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
10 Quetglas JI, John LB, Kershaw MH, Alvarez-Vallina L, Melero I, Darcy PK, Smerdou C. Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. Oncoimmunology 2012;1:1344-54. [PMID: 23243597 DOI: 10.4161/onci.21679] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
11 Doi K, Leelahavanichkul A, Yuen PS, Star RA. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 2009;119:2868-78. [PMID: 19805915 DOI: 10.1172/JCI39421] [Cited by in Crossref: 339] [Cited by in F6Publishing: 198] [Article Influence: 26.1] [Reference Citation Analysis]
12 Techarang T, Jariyapong P, Viriyavejakul P, Glaharn S, Srisook C, Punsawad C. Protective Effect of an Anti-HMGB-1 Neutralizing Antibody on Hemozoin-Induced Alveolar Epithelial Cell in a Model of Malaria Associated ALI/ARDS. Iran J Parasitol 2021;16:366-76. [PMID: 34630581 DOI: 10.18502/ijpa.v16i3.7089] [Reference Citation Analysis]
13 Zhang W, Wang LW, Wang LK, Li X, Zhang H, Luo LP, Song JC, Gong ZJ. Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats. Dig Dis Sci. 2013;58:3198-3206. [PMID: 23861108 DOI: 10.1007/s10620-013-2775-x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
14 Yang D, de la Rosa G, Tewary P, Oppenheim JJ. Alarmins link neutrophils and dendritic cells. Trends Immunol. 2009;30:531-537. [PMID: 19699678 DOI: 10.1016/j.it.2009.07.004] [Cited by in Crossref: 161] [Cited by in F6Publishing: 149] [Article Influence: 12.4] [Reference Citation Analysis]
15 Gou X, Ying J, Yue Y, Qiu X, Hu P, Qu Y, Li J, Mu D. The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury. Front Cell Neurosci 2020;14:600280. [PMID: 33384585 DOI: 10.3389/fncel.2020.600280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Abarbanell AM, Wang Y, Herrmann JL, Weil BR, Poynter JA, Manukyan MC, Meldrum DR. Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2010;298:H1529-36. [PMID: 20173040 DOI: 10.1152/ajpheart.01087.2009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
17 Kuhn A, Wenzel J, Bijl M. Lupus erythematosus revisited. Semin Immunopathol 2016;38:97-112. [PMID: 26637330 DOI: 10.1007/s00281-015-0550-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
18 Valdés-Ferrer SI, Rosas-Ballina M, Olofsson PS, Lu B, Dancho ME, Li J, Yang H, Pavlov VA, Chavan SS, Tracey KJ. High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model. Shock 2013;40:492-5. [PMID: 24089009 DOI: 10.1097/SHK.0000000000000050] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
19 Bierhaus A, Nawroth PP. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009;52:2251-63. [DOI: 10.1007/s00125-009-1458-9] [Cited by in Crossref: 192] [Cited by in F6Publishing: 177] [Article Influence: 14.8] [Reference Citation Analysis]
20 Wang L, Xiaokaiti Y, Wang G, Xu X, Chen L, Huang X, Liu L, Pan J, Hu S, Chen Z, Xu Y. Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA/PKG-dependent neuro-inflammatory and apoptotic pathways. Sci Rep 2017;7:12044. [PMID: 28935920 DOI: 10.1038/s41598-017-08070-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
21 Weigt SS, Palchevskiy V, Belperio JA. Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction. J Clin Invest 2017;127:2022-9. [PMID: 28569730 DOI: 10.1172/JCI93537] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
22 Manganelli V, Signore M, Pacini I, Misasi R, Tellan G, Garofalo T, Lococo E, Chirletti P, Sorice M, Delogu G. Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma. Crit Care 2010;14:R197. [PMID: 21044333 DOI: 10.1186/cc9316] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
23 Mittal D, Saccheri F, Vénéreau E, Pusterla T, Bianchi ME, Rescigno M. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J 2010;29:2242-52. [PMID: 20526283 DOI: 10.1038/emboj.2010.94] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 9.7] [Reference Citation Analysis]
24 Chen XL, Sun L, Guo F, Wang F, Liu S, Liang X, Wang RS, Wang YJ, Sun YX. High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injury. PLoS One. 2012;7:e50668. [PMID: 23209806 DOI: 10.1371/journal.] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
25 Yang, Han Z, Oppenheim JJ. Alarmins and immunity. Immunol Rev 2017;280:41-56. [PMID: 29027222 DOI: 10.1111/imr.12577] [Cited by in Crossref: 130] [Cited by in F6Publishing: 129] [Article Influence: 32.5] [Reference Citation Analysis]
26 Penzo M, Molteni R, Suda T, Samaniego S, Raucci A, Habiel DM, Miller F, Jiang HP, Li J, Pardi R, Palumbo R, Olivotto E, Kew RR, Bianchi ME, Marcu KB. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]. J Immunol. 2010;184:4497-4509. [PMID: 20231695 DOI: 10.4049/jimmunol.0903131] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.0] [Reference Citation Analysis]
27 Terrando N, Monaco C, Ma D, Foxwell BM, Feldmann M, Maze M. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A 2010;107:20518-22. [PMID: 21041647 DOI: 10.1073/pnas.1014557107] [Cited by in Crossref: 414] [Cited by in F6Publishing: 395] [Article Influence: 34.5] [Reference Citation Analysis]
28 Vacas S, Degos V, Tracey KJ, Maze M. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology 2014;120:1160-7. [PMID: 24162463 DOI: 10.1097/ALN.0000000000000045] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 10.9] [Reference Citation Analysis]
29 Kamo N, Ke B, Ghaffari AA, Shen XD, Busuttil RW, Cheng G, Kupiec-Weglinski JW. ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 2013;58:351-62. [PMID: 23408710 DOI: 10.1002/hep.26320] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 12.8] [Reference Citation Analysis]
30 Bobek D, Grčević D, Kovačić N, Lukić IK, Jelušić M. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Pediatr Rheumatol Online J 2014;12:50. [PMID: 25516724 DOI: 10.1186/1546-0096-12-50] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
31 Tamura Y, Chiba Y, Tanioka T, Shimizu N, Shinozaki S, Yamada M, Kaneki K, Mori S, Araki A, Ito H. NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells. FEBS Lett. 2011;585:3058-3064. [PMID: 21888904 DOI: 10.1016/j.febslet.2011.08.028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
32 Devi TS, Lee I, Hüttemann M, Kumar A, Nantwi KD, Singh LP. TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res. 2012;2012:438238. [PMID: 22474421 DOI: 10.1155/2012/438238] [Cited by in Crossref: 98] [Cited by in F6Publishing: 114] [Article Influence: 9.8] [Reference Citation Analysis]
33 von Bauer R, Oikonomou D, Sulaj A, Mohammed S, Hotz-Wagenblatt A, Gröne HJ, Arnold B, Falk C, Luethje D, Erhardt A, Stern DM, Bierhaus A, Nawroth PP. CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivity. J Immunol 2013;191:369-77. [PMID: 23729438 DOI: 10.4049/jimmunol.1201864] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
34 Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010;37:439-79. [PMID: 20569817 DOI: 10.1016/j.clp.2010.04.002] [Cited by in Crossref: 111] [Cited by in F6Publishing: 83] [Article Influence: 9.3] [Reference Citation Analysis]
35 Hu Z, Wang X, Gong L, Wu G, Peng X, Tang X. Role of high-mobility group box 1 protein in inflammatory bowel disease. Inflamm Res 2015;64:557-63. [PMID: 26077468 DOI: 10.1007/s00011-015-0841-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
36 Kessler EL, Wang JW, Kok B, Brans MA, Nederlof A, van Stuijvenberg L, Huang C, Vink A, Arslan F, Efimov IR, Lam CSP, Vos MA, de Kleijn DPV, Fontes MSC, van Veen TAB. Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice. Int J Mol Sci 2021;22:11823. [PMID: 34769252 DOI: 10.3390/ijms222111823] [Reference Citation Analysis]
37 Yang QW, Wang JZ, Li JC, Zhou Y, Zhong Q, Lu FL, Xiang J. High-mobility group protein box-1 and its relevance to cerebral ischemia. J Cereb Blood Flow Metab 2010;30:243-54. [PMID: 19794402 DOI: 10.1038/jcbfm.2009.202] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 4.8] [Reference Citation Analysis]
38 Begum S, Moreau F, Leon Coria A, Chadee K. Entamoeba histolytica stimulates the alarmin molecule HMGB1 from macrophages to amplify innate host defenses. Mucosal Immunol 2020;13:344-56. [PMID: 31772322 DOI: 10.1038/s41385-019-0233-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li J, Zhao J, Xu M, Li M, Wang B, Qu X, Yu C, Hang H, Xia Q, Wu H, Sun X, Gu J, Kong X. Blocking GSDMD processing in innate immune cells but not in hepatocytes protects hepatic ischemia-reperfusion injury. Cell Death Dis 2020;11:244. [PMID: 32303674 DOI: 10.1038/s41419-020-2437-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
40 Palmer CD, Mancuso CJ, Weiss JP, Serhan CN, Guinan EC, Levy O. 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. J Leukoc Biol 2011;90:459-70. [PMID: 21653234 DOI: 10.1189/jlb.0311145] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
41 Celik IH, Hanna M, Canpolat FE, Mohan Pammi. Diagnosis of neonatal sepsis: the past, present and future. Pediatr Res 2021. [PMID: 34728808 DOI: 10.1038/s41390-021-01696-z] [Reference Citation Analysis]
42 Liu K, Zhang X, Cao G, Liu Y, Liu C, Sun H, Pang X. Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model. Int J Nanomedicine 2016;11:2587-99. [PMID: 27354791 DOI: 10.2147/IJN.S103183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Sharma J, Mares CA, Li Q, Morris EG, Teale JM. Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain. Microb Pathog 2011;51:39-47. [PMID: 21440052 DOI: 10.1016/j.micpath.2011.03.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
44 Wagner G, Lehmann C, Bode C, Miosge N, Schubert A. High Mobility Group Box 1 Protein in Osteoarthritic Knee Tissue and Chondrogenic Progenitor Cells: An Ex Vivo and In Vitro Study. Cartilage 2021;12:484-95. [PMID: 30912672 DOI: 10.1177/1947603519835897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
45 Buckley ST, Ehrhardt C. The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010;2010:917108. [PMID: 20145712 DOI: 10.1155/2010/917108] [Cited by in Crossref: 128] [Cited by in F6Publishing: 133] [Article Influence: 10.7] [Reference Citation Analysis]
46 Baumbusch MA, Buhimschi CS, Oliver EA, Zhao G, Thung S, Rood K, Buhimschi IA. High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes. Cytokine 2016;81:82-7. [PMID: 26954343 DOI: 10.1016/j.cyto.2016.02.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
47 Dandona P, Ghanim H, Bandyopadhyay A, Korzeniewski K, Ling Sia C, Dhindsa S, Chaudhuri A. Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care 2010;33:2416-23. [PMID: 20699433 DOI: 10.2337/dc10-0929] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
48 Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mol Med. 2012;18:477-485. [PMID: 22314397 DOI: 10.2119/molmed.2012.00024] [Cited by in Crossref: 59] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
49 Dugan CM, Fullerton AM, Roth RA, Ganey PE. Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis. Toxicol Sci 2011;120:507-18. [PMID: 21245496 DOI: 10.1093/toxsci/kfr005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
50 Wang T, Wei XY, Liu B, Wang LJ, Jiang LH. Effects of propofol on lipopolysaccharide-induced expression and release of HMGB1 in macrophages. Braz J Med Biol Res 2015;48:286-91. [PMID: 25714879 DOI: 10.1590/1414-431X20144222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
51 Kang JH, Hwang SM, Chung IY. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways. Immunology 2015;144:79-90. [PMID: 24975020 DOI: 10.1111/imm.12352] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 11.9] [Reference Citation Analysis]
52 Clark IA, Vissel B. Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases. Br J Pharmacol 2018;175:3859-75. [PMID: 30097997 DOI: 10.1111/bph.14471] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
53 Saenz R, Souza Cda S, Huang CT, Larsson M, Esener S, Messmer D. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen. Vaccine 2010;28:7556-62. [PMID: 20800114 DOI: 10.1016/j.vaccine.2010.08.054] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
54 Tillmann S, Bernhagen J, Noels H. Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis. Front Immunol 2013;4:115. [PMID: 23720662 DOI: 10.3389/fimmu.2013.00115] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
55 Nair A, Kanda V, Bush-Joseph C, Verma N, Chubinskaya S, Mikecz K, Glant TT, Malfait AM, Crow MK, Spear GT, Finnegan A, Scanzello CR. Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis Rheum 2012;64:2268-77. [PMID: 22492243 DOI: 10.1002/art.34495] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
56 Lee CH, Yoon SJ, Lee SM. Chlorogenic acid attenuates high mobility group box 1 (HMGB1) and enhances host defense mechanisms in murine sepsis. Mol Med. 2012;18:1437-1448. [PMID: 23168580 DOI: 10.2119/molmed.2012.00279] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
57 Wang H, Ward MF, Sama AE. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock. 2009;32:348-357. [PMID: 19333143 DOI: 10.1097/SHK.0b013e3181a551bd] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
58 Nieto-Quero A, Chaves-Peña P, Santín LJ, Pérez-Martín M, Pedraza C. Do changes in microglial status underlie neurogenesis impairments and depressive-like behaviours induced by psychological stress? A systematic review in animal models. Neurobiol Stress 2021;15:100356. [PMID: 34355047 DOI: 10.1016/j.ynstr.2021.100356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Fang P, Schachner M, Shen YQ. HMGB1 in development and diseases of the central nervous system. Mol Neurobiol 2012;45:499-506. [PMID: 22580958 DOI: 10.1007/s12035-012-8264-y] [Cited by in Crossref: 118] [Cited by in F6Publishing: 116] [Article Influence: 11.8] [Reference Citation Analysis]
60 Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010;1799:149-156. [PMID: 19948257 DOI: 10.1016/j.bbagrm.2009.11.019] [Cited by in Crossref: 224] [Cited by in F6Publishing: 231] [Article Influence: 17.2] [Reference Citation Analysis]
61 Abdulmahdi W, Patel D, Rabadi MM, Azar T, Jules E, Lipphardt M, Hashemiyoon R, Ratliff BB. HMGB1 redox during sepsis. Redox Biol. 2017;13:600-607. [PMID: 28806702 DOI: 10.1016/j.redox.2017.08.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
62 Furlani D, Donndorf P, Westien I, Ugurlucan M, Pittermann E, Wang W, Li W, Vollmar B, Steinhoff G, Kaminski A, Ma N. HMGB-1 induces c-kit+ cell microvascular rolling and adhesion via both toll-like receptor-2 and toll-like receptor-4 of endothelial cells. J Cell Mol Med 2012;16:1094-105. [PMID: 21762373 DOI: 10.1111/j.1582-4934.2011.01381.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
63 Jiang L, Ke M, Yue S, Xiao W, Yan Y, Deng X, Ying QL, Li J, Ke B. Blockade of Notch signaling promotes acetaminophen-induced liver injury. Immunol Res 2017;65:739-49. [PMID: 28286920 DOI: 10.1007/s12026-017-8913-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
64 Zhao F, Fang Y, Deng S, Li X, Zhou Y, Gong Y, Zhu H, Wang W. Glycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 Signaling. Biomed Res Int 2017;2017:9719647. [PMID: 28484719 DOI: 10.1155/2017/9719647] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
65 Deng M, Scott MJ, Fan J, Billiar TR. Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation. J Leukoc Biol 2019;106:161-9. [PMID: 30946496 DOI: 10.1002/JLB.3MIR1218-497R] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
66 Lin Q, Yang XP, Fang D, Ren X, Zhou H, Fang J, Liu X, Zhou S, Wen F, Yao X, Wang JM, Su SB. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler Thromb Vasc Biol 2011;31:1024-32. [PMID: 21372296 DOI: 10.1161/ATVBAHA.111.224048] [Cited by in Crossref: 69] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
67 Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res 2014;15:148. [PMID: 25420924 DOI: 10.1186/s12931-014-0148-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
68 Barlan AU, Griffin TM, McGuire KA, Wiethoff CM. Adenovirus membrane penetration activates the NLRP3 inflammasome. J Virol 2011;85:146-55. [PMID: 20980503 DOI: 10.1128/JVI.01265-10] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
69 Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010;1799:149-156. [PMID: 19948257 DOI: 10.1016/j.bbagrm.2009.11. 019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Syed DN, Aljohani A, Waseem D, Mukhtar H. Ousting RAGE in melanoma: A viable therapeutic target? Semin Cancer Biol 2018;49:20-8. [PMID: 29079306 DOI: 10.1016/j.semcancer.2017.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
71 Wang D, Liu K, Wake H, Teshigawara K, Mori S, Nishibori M. Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats. Sci Rep 2017;7:46243. [PMID: 28393932 DOI: 10.1038/srep46243] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
72 Chen XL, Sun L, Guo F, Wang F, Liu S, Liang X, Wang RS, Wang YJ, Sun YX. High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injury. PLoS One 2012;7:e50668. [PMID: 23209806 DOI: 10.1371/journal.pone.0050668] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
73 Wang C, Chang DY, Chen M, Zhao MH. HMGB1 contributes to glomerular endothelial cell injury in ANCA-associated vasculitis through enhancing endothelium-neutrophil interactions. J Cell Mol Med 2017;21:1351-60. [PMID: 28181422 DOI: 10.1111/jcmm.13065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
74 Ekanayaka SA, McClellan SA, Peng X, Barrett RP, Francis R, Hazlett LD. HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice. J Ocul Pharmacol Ther 2018. [PMID: 30407111 DOI: 10.1089/jop.2018.0073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
75 Sukkar MB, Ullah MA, Gan WJ, Wark PA, Chung KF, Hughes JM, Armour CL, Phipps S. RAGE: a new frontier in chronic airways disease. Br J Pharmacol 2012;167:1161-76. [PMID: 22506507 DOI: 10.1111/j.1476-5381.2012.01984.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
76 Xiang M, Yin L, Li Y, Xiao G, Vodovotz Y, Billiar TR, Wilson MA, Fan J. Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase. Am J Respir Cell Mol Biol 2011;44:333-40. [PMID: 20418360 DOI: 10.1165/rcmb.2009-0408OC] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
77 Terrando N, Rei Fidalgo A, Vizcaychipi M, Cibelli M, Ma D, Monaco C, Feldmann M, Maze M. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care 2010;14:R88. [PMID: 20470406 DOI: 10.1186/cc9019] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 12.0] [Reference Citation Analysis]
78 Liu Y, Xiang X, Zhuang X, Zhang S, Liu C, Cheng Z, Michalek S, Grizzle W, Zhang HG. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am J Pathol 2010;176:2490-9. [PMID: 20348242 DOI: 10.2353/ajpath.2010.090777] [Cited by in Crossref: 152] [Cited by in F6Publishing: 147] [Article Influence: 12.7] [Reference Citation Analysis]
79 Zhang C, Gu X, Zhao G, Wang W, Shao J, Zhu J, Yuan T, Sun J, Nie D, Zhou Y. Extracellular HMGB-1 activates inflammatory signaling in tendon cells and tissues. Ther Adv Chronic Dis 2020;11:2040622320956429. [PMID: 32963751 DOI: 10.1177/2040622320956429] [Reference Citation Analysis]
80 Hu Z, Wang XY, Gong L, Wu GJ, Peng XB. Expression of high mobility group box 1 protein in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3239-3244 [DOI: 10.11569/wcjd.v22.i22.3239] [Reference Citation Analysis]
81 Srikrishna G, Freeze HH. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009;11:615-28. [PMID: 19568407 DOI: 10.1593/neo.09284] [Cited by in Crossref: 178] [Cited by in F6Publishing: 176] [Article Influence: 13.7] [Reference Citation Analysis]
82 Das N, Dewan V, Grace PM, Gunn RJ, Tamura R, Tzarum N, Watkins LR, Wilson IA, Yin H. HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia. Cell Rep 2016;17:1128-40. [PMID: 27760316 DOI: 10.1016/j.celrep.2016.09.076] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 14.2] [Reference Citation Analysis]
83 Li DC, Bao XQ, Wang XL, Sun H, Zhang D. A novel synthetic derivative of squamosamide FLZ inhibits the high mobility group box 1 protein-mediated neuroinflammatory responses in murine BV2 microglial cells. Naunyn Schmiedebergs Arch Pharmacol 2017;390:643-50. [PMID: 28280849 DOI: 10.1007/s00210-017-1363-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
84 Achouiti A, van der Meer AJ, Florquin S, Yang H, Tracey KJ, van 't Veer C, de Vos AF, van der Poll T. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia. Crit Care 2013;17:R296. [PMID: 24342460 DOI: 10.1186/cc13162] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
85 Valdés-Ferrer SI, Rosas-Ballina M, Olofsson PS, Lu B, Dancho ME, Ochani M, Li JH, Scheinerman JA, Katz DA, Levine YA, Hudson LK, Yang H, Pavlov VA, Roth J, Blanc L, Antoine DJ, Chavan SS, Andersson U, Diamond B, Tracey KJ. HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivors. J Intern Med 2013;274:381-90. [PMID: 23808943 DOI: 10.1111/joim.12104] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
86 Schaper F, Westra J, Bijl M. Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus. Mol Med 2014;20:72-9. [PMID: 24531837 DOI: 10.2119/molmed.2014.00019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
87 Gale SC, Shanker BA, Coyle SM, Macor MA, Choi CW, Calvano SE, Corbett SA, Lowry SF. Continuous enteral and parenteral feeding each reduces heart rate variability but differentially influences monocyte gene expression in humans. Shock 2012;38:255-61. [PMID: 22777119 DOI: 10.1097/SHK.0b013e31826171b9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
88 Wang G, Han D, Zhang Y, Xie X, Wu Y, Li S, Li M. A novel hypothesis: up-regulation of HO-1 by activation of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS. J Thorac Dis 2013;5:706-10. [PMID: 24255785 DOI: 10.3978/j.issn.2072-1439.2013.08.69] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
89 Peng HH, Liu YJ, Ojcius DM, Lee CM, Chen RH, Huang PR, Martel J, Young JD. Mineral particles stimulate innate immunity through neutrophil extracellular traps containing HMGB1. Sci Rep 2017;7:16628. [PMID: 29192209 DOI: 10.1038/s41598-017-16778-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
90 Xu J, Jiang Y, Wang J, Shi X, Liu Q, Liu Z, Li Y, Scott MJ, Xiao G, Li S, Fan L, Billiar TR, Wilson MA, Fan J. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ 2014;21:1229-39. [PMID: 24769733 DOI: 10.1038/cdd.2014.40] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 13.8] [Reference Citation Analysis]
91 van den Bosch MHJ. Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease? Clin Exp Immunol 2019;195:153-66. [PMID: 30421798 DOI: 10.1111/cei.13237] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
92 Lamkanfi M, Sarkar A, Vande Walle L, Vitari AC, Amer AO, Wewers MD, Tracey KJ, Kanneganti TD, Dixit VM. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol. 2010;185:4385-4392. [PMID: 20802146 DOI: 10.4049/jimmunol.1000803] [Cited by in Crossref: 298] [Cited by in F6Publishing: 295] [Article Influence: 24.8] [Reference Citation Analysis]
93 Yoshizaki A, Komura K, Iwata Y, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol 2009;29:180-9. [PMID: 18825489 DOI: 10.1007/s10875-008-9252-x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
94 Han L, Zhang M, Wang M, Jia J, Zhao M, Fan Y, Li X. High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway. PLoS One 2016;11:e0154187. [PMID: 27100831 DOI: 10.1371/journal.pone.0154187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
95 Wang TH, Xiong LL, Yang SF, You C, Xia QJ, Xu Y, Zhang P, Wang SF, Liu J. LPS Pretreatment Provides Neuroprotective Roles in Rats with Subarachnoid Hemorrhage by Downregulating MMP9 and Caspase3 Associated with TLR4 Signaling Activation. Mol Neurobiol 2017;54:7746-60. [PMID: 27844284 DOI: 10.1007/s12035-016-0259-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
96 Prantner D, Nallar S, Vogel SN. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways. FASEB J 2020;34:15659-74. [PMID: 33131091 DOI: 10.1096/fj.202002136R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
97 Vande Walle L, Kanneganti TD, Lamkanfi M. HMGB1 release by inflammasomes. Virulence 2011;2:162-5. [PMID: 21422809 DOI: 10.4161/viru.2.2.15480] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
98 Monden M, Koyama H, Otsuka Y, Morioka T, Mori K, Shoji T, Mima Y, Motoyama K, Fukumoto S, Shioi A, Emoto M, Yamamoto Y, Yamamoto H, Nishizawa Y, Kurajoh M, Yamamoto T, Inaba M. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2. Diabetes. 2013;62:478-489. [PMID: 23011593 DOI: 10.2337/db11-1116] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
99 Zhu CJ, Yang WG, Li DJ, Song YD, Chen SY, Wang QF, Liu YN, Zhang Y, Cheng B, Wu ZW, Cui ZC. Calycosin attenuates severe acute pancreatitis-associated acute lung injury by curtailing high mobility group box 1 - induced inflammation. World J Gastroenterol 2021; 27(44): 7669-7686 [PMID: 34908806 DOI: 10.3748/wjg.v27.i44.7669] [Reference Citation Analysis]
100 Saenz R, Futalan D, Leutenez L, Eekhout F, Fecteau JF, Sundelius S, Sundqvist S, Larsson M, Hayashi T, Minev B, Carson D, Esener S, Messmer B, Messmer D. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med. 2014;12:211. [PMID: 25123824 DOI: 10.1186/1479-5876-12-211] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
101 Manti S, Harford TJ, Salpietro C, Rezaee F, Piedimonte G. Induction of high-mobility group Box-1 in vitro and in vivo by respiratory syncytial virus. Pediatr Res 2018;83:1049-56. [PMID: 29329282 DOI: 10.1038/pr.2018.6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
102 Nadatani Y, Watanabe T, Tanigawa T, Ohkawa F, Takeda S, Higashimori A, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Takeuchi K, Arakawa T. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products. PLoS One 2013;8:e80130. [PMID: 24244627 DOI: 10.1371/journal.pone.0080130] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
103 Renfeng Q, Shuxiao C, Peixian G, Kun L, Xuedong F, Hai Y, Xuejun W, Gang L. ADAM10 attenuates the development of abdominal aortic aneurysms in a mouse model. Mol Med Rep 2021;24:774. [PMID: 34490486 DOI: 10.3892/mmr.2021.12414] [Reference Citation Analysis]
104 Kirk SG, Samavati L, Liu Y. MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response. Life Sci 2020;241:117157. [PMID: 31837332 DOI: 10.1016/j.lfs.2019.117157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
105 Bajwa E, Pointer CB, Klegeris A. The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation. Mediators Inflamm 2019;2019:4050796. [PMID: 31065234 DOI: 10.1155/2019/4050796] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
106 Pang H, Huang T, Song J, Li D, Zhao Y, Ma X. Inhibiting HMGB1 with Glycyrrhizic Acid Protects Brain Injury after DAI via Its Anti-Inflammatory Effect. Mediators Inflamm 2016;2016:4569521. [PMID: 27041825 DOI: 10.1155/2016/4569521] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
107 Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q, Lin S, Xiang J, Li JC, Fang CQ, Wang JZ. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab. 2011;31:593-605. [PMID: 20700129 DOI: 10.1038/jcbfm.2010.129] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
108 van Zoelen MA, Achouiti A, Schmidt AM, Yang H, Florquin S, Tracey KJ, van der Poll T. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis. Crit Care Med 2010;38:1414-22. [PMID: 20386310 DOI: 10.1097/CCM.0b013e3181de18bc] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
109 Gong W, Zheng Y, Chao F, Li Y, Xu Z, Huang G, Gao X, Li S, He F. The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail. J Biomed Biotechnol. 2010;2010:915234. [PMID: 20379370 DOI: 10.1155/2010/915234] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
110 Aluganti Narasimhulu C, Singla DK. Amelioration of diabetes-induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein-7. J Cachexia Sarcopenia Muscle 2021;12:403-20. [PMID: 33463042 DOI: 10.1002/jcsm.12662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
111 Tewary P, Yang D, de la Rosa G, Li Y, Finn MW, Krensky AM, Clayberger C, Oppenheim JJ. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 2010;116:3465-74. [PMID: 20660289 DOI: 10.1182/blood-2010-03-273953] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
112 Lagomarsino VN, Kostic AD, Chiu IM. Mechanisms of microbial-neuronal interactions in pain and nociception. Neurobiol Pain 2021;9:100056. [PMID: 33392418 DOI: 10.1016/j.ynpai.2020.100056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
113 Duque Ede A, Munhoz CD. The Pro-inflammatory Effects of Glucocorticoids in the Brain. Front Endocrinol (Lausanne) 2016;7:78. [PMID: 27445981 DOI: 10.3389/fendo.2016.00078] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
114 Zhao G, Fu C, Wang L, Zhu L, Yan Y, Xiang Y, Zheng F, Gong F, Chen S, Chen G. Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury. Sci Rep 2017;7:46272. [PMID: 28382970 DOI: 10.1038/srep46272] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
115 Moreira J, Costelha S, Saraiva M, Saraiva MJ. The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis. Front Immunol 2021;12:650269. [PMID: 34093538 DOI: 10.3389/fimmu.2021.650269] [Reference Citation Analysis]
116 Weber MD, Frank MG, Tracey KJ, Watkins LR, Maier SF. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome. J Neurosci 2015;35:316-24. [PMID: 25568124 DOI: 10.1523/JNEUROSCI.3561-14.2015] [Cited by in Crossref: 131] [Cited by in F6Publishing: 83] [Article Influence: 18.7] [Reference Citation Analysis]
117 Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res. 2010;106:842-853. [PMID: 20299674 DOI: 10.1161/circresaha.109.212217] [Cited by in Crossref: 243] [Cited by in F6Publishing: 148] [Article Influence: 20.3] [Reference Citation Analysis]
118 Guan Z, Hellman J, Schumacher M. Contemporary views on inflammatory pain mechanisms: TRPing over innate and microglial pathways. F1000Res 2016;5:F1000 Faculty Rev-2425. [PMID: 27781082 DOI: 10.12688/f1000research.8710.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
119 Gunawardena D, Shanmugam K, Low M, Bennett L, Govindaraghavan S, Head R, Ooi L, Münch G. Determination of anti-inflammatory activities of standardised preparations of plant- and mushroom-based foods. Eur J Nutr 2014;53:335-43. [PMID: 23653285 DOI: 10.1007/s00394-013-0531-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
120 Guo WA, Davidson BA, Ottosen J, Ohtake PJ, Raghavendran K, Mullan BA, Dayton MT, Knight PR 3rd. Effect of high advanced glycation end-product diet on pulmonary inflammatory response and pulmonary function following gastric aspiration. Shock 2012;38:677-84. [PMID: 23143059 DOI: 10.1097/SHK.0b013e318273982e] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]